<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font19 { font-size : 19; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">influenza </span>
   <span class="font19">virus </span>
   <span class="font17">[]. </span>
   <span class="font16">vaccine </span>
   <span class="font16">viruses </span>
   <span class="font14">vaccines </span>
   <span class="font14">viral </span>
   <span class="font13">Influenza </span>
   <span class="font13">antibodies </span>
   <span class="font12">protection </span>
   <span class="font12">mice </span>
   <span class="font12">shown </span>
   <span class="font12">[,]. </span>
   <span class="font12">broadly </span>
   <span class="font12">use </span>
   <span class="font12">{border-style </span>
   <span class="font11">antibody </span>
   <span class="font11">human </span>
   <span class="font11">immunity </span>
   <span class="font11">protein </span>
   <span class="font11">cell </span>
   <span class="font11">cells </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">seasonal </span>
   <span class="font11">drug </span>
   <span class="font11">neutralizing </span>
   <span class="font11">efficacy </span>
   <span class="font11">immune </span>
   <span class="font11">novel </span>
   <span class="font11">protective </span>
   <span class="font11">VLPs </span>
   <span class="font11">Vaccines </span>
   <span class="font11">treatment </span>
   <span class="font11">antigenic </span>
   <span class="font11">antiviral </span>
   <span class="font11">host </span>
   <span class="font11">passive </span>
   <span class="font11">III </span>
   <span class="font11">Infect. </span>
   <span class="font11">infection </span>
   <span class="font11">phase </span>
   <span class="font11">Virol../JVI.- </span>
   <span class="font11">clinical </span>
   <span class="font11">strains </span>
   <span class="font11">surface </span>
   <span class="font11">viruses, </span>
   <span class="font11">LAIV </span>
   <span class="font11">Vaccine </span>
   <span class="font11">highly </span>
   <span class="font11">induce </span>
   <span class="font11">monoclonal </span>
   <span class="font11">trial </span>
   <span class="font11">vaccination </span>
   <span class="font11">vaccines, </span>
   <span class="font10">(HN) </span>
   <span class="font10">Res../j.antiviral... </span>
   <span class="font10">avian </span>
   <span class="font10">challenge </span>
   <span class="font10">fusion </span>
   <span class="font10">immunotherapy </span>
   <span class="font10">lethal </span>
   <span class="font10">management </span>
   <span class="font10">respiratory </span>
   <span class="font10">response </span>
   <span class="font10">virus, </span>
   <span class="font10">Agents </span>
   <span class="font10">RNA </span>
   <span class="font10">Virus </span>
   <span class="font10">[,,]. </span>
   <span class="font10">based </span>
   <span class="font10">broad-spectrum </span>
   <span class="font10">completed </span>
   <span class="font10">demonstrated </span>
   <span class="font10">development </span>
   <span class="font10">epitope </span>
   <span class="font10">induction </span>
   <span class="font10">infections </span>
   <span class="font10">inhibitor </span>
   <span class="font10">natural </span>
   <span class="font10">potential </span>
   <span class="font10">proteins </span>
   <span class="font10">px; </span>
   <span class="font10">resistance </span>
   <span class="font10">specific </span>
   <span class="font10">stem </span>
   <span class="font10">used </span>
   <span class="font10">{font-family </span>
   <span class="font10">Clin. </span>
   <span class="font10">USA </span>
   <span class="font10">antibody-dependent </span>
   <span class="font10">approach </span>
   <span class="font10">children </span>
   <span class="font10">developed </span>
   <span class="font10">font-size </span>
   <span class="font10">group </span>
   <span class="font10">immunization </span>
   <span class="font10">including </span>
   <span class="font10">infected </span>
   <span class="font10">multivalent </span>
   <span class="font10">new </span>
   <span class="font10">polymerase </span>
   <span class="font10">showed </span>
   <span class="font10">single </span>
   <span class="font10">subunit </span>
   <span class="font10">Acad. </span>
   <span class="font10">ability </span>
   <span class="font10">acid </span>
   <span class="font10">administration </span>
   <span class="font10">anti-influenza </span>
   <span class="font10">antigen </span>
   <span class="font10">antivirals </span>
   <span class="font10">approved </span>
   <span class="font10">capacity </span>
   <span class="font10">comprise </span>
   <span class="font10">conserved </span>
   <span class="font10">domain </span>
   <span class="font10">double; </span>
   <span class="font10">hemagglutinin </span>
   <span class="font10">immunized </span>
   <span class="font10">inhibits </span>
   <span class="font10">multiple </span>
   <span class="font10">neuraminidase </span>
   <span class="font10">pandemic </span>
   <span class="font10">particles </span>
   <span class="font10">pathogenic </span>
   <span class="font10">protects </span>
   <span class="font10">rapid </span>
   <span class="font10">resulted </span>
   <span class="font10">stalk </span>
   <span class="font10">target </span>
   <span class="font10">targeting </span>
   <span class="font10">trials </span>
   <span class="font10">universal </span>
   <span class="font10">viruses. </span>
   <span class="font10">COBRA </span>
   <span class="font10">Chemother../AAC.- </span>
   <span class="font10">Ebola </span>
   <span class="font10">However, </span>
   <span class="font10">IIV </span>
   <span class="font10">Natl. </span>
   <span class="font10">Novel </span>
   <span class="font10">Phase </span>
   <span class="font10">Russia </span>
   <span class="font10">Sci. </span>
   <span class="font10">antigen-presenting </span>
   <span class="font10">approaches </span>
   <span class="font10">associated </span>
   <span class="font10">attenuated </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cellular </span>
   <span class="font10">containing </span>
   <span class="font10">control </span>
   <span class="font10">currently </span>
   <span class="font10">delivery </span>
   <span class="font10">efficacious </span>
   <span class="font10">generate </span>
   <span class="font10">generated </span>
   <span class="font10">humans </span>
   <span class="font10">humoral </span>
   <span class="font10">inhibit </span>
   <span class="font10">inhibitors </span>
   <span class="font10">mechanism </span>
   <span class="font10">need </span>
   <span class="font10">observed </span>
   <span class="font10">optimized </span>
   <span class="font10">pathogens </span>
   <span class="font10">persons </span>
   <span class="font10">promising </span>
   <span class="font10">recombinant </span>
   <span class="font10">recruiting </span>
   <span class="font10">replication </span>
   <span class="font10">solid; </span>
   <span class="font10">vaccine: </span>
   <span class="font10">virus-like </span>
   <span class="font10">vitro </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(COBRA) </span>
   <span class="font10">A(HN) </span>
   <span class="font10">Antibody </span>
   <span class="font10">Arbidol </span>
   <span class="font10">Broadly </span>
   <span class="font10">Computationally </span>
   <span class="font10">HA, </span>
   <span class="font10">Japan </span>
   <span class="font10">Management </span>
   <span class="font10">ONEe./journal.pone. </span>
   <span class="font10">Pimodivir </span>
   <span class="font10">Seasonal </span>
   <span class="font10">Table </span>
   <span class="font10">[,,,,,,] </span>
   <span class="font10">acting </span>
   <span class="font10">active </span>
   <span class="font10">activity </span>
   <span class="font10">acute </span>
   <span class="font10">addition </span>
   <span class="font10">administered </span>
   <span class="font10">bold </span>
   <span class="font10">broad </span>
   <span class="font10">burden </span>
   <span class="font10">cell-mediated </span>
   <span class="font10">challenges </span>
   <span class="font10">circulating </span>
   <span class="font10">colleagues </span>
   <span class="font10">computationally </span>
   <span class="font10">contribute </span>
   <span class="font10">conventional </span>
   <span class="font10">courier; </span>
   <span class="font10">designed </span>
   <span class="font10">different </span>
   <span class="font10">diverse </span>
   <span class="font10">drifts </span>
   <span class="font10">effective </span>
   <span class="font10">em; </span>
   <span class="font10">escape </span>
   <span class="font10">evolution </span>
   <span class="font10">expressed </span>
   <span class="font10">following </span>
   <span class="font10">global </span>
   <span class="font10">head </span>
   <span class="font10">higher </span>
   <span class="font10">increased </span>
   <span class="font10">infection. </span>
   <span class="font10">influenza, </span>
   <span class="font10">involved </span>
   <span class="font10">ion </span>
   <span class="font10">isolated </span>
   <span class="font10">live </span>
   <span class="font10">matrix </span>
   <span class="font10">mechanisms </span>
   <span class="font10">molecules </span>
   <span class="font10">mucosal </span>
   <span class="font10">nanoparticle </span>
   <span class="font10">ongoing </span>
   <span class="font10">platforms </span>
   <span class="font10">possible </span>
   <span class="font10">previously </span>
   <span class="font10">process </span>
   <span class="font10">protect </span>
   <span class="font10">pt;} </span>
   <span class="font10">raised </span>
   <span class="font10">reactive </span>
   <span class="font10">relief </span>
   <span class="font10">respectively </span>
   <span class="font10">sialidase </span>
   <span class="font10">similar </span>
   <span class="font10">subtypes </span>
   <span class="font10">syncytial </span>
   <span class="font10">types </span>
   <span class="font10">vaccines: </span>
   <span class="font10">variable </span>
   <span class="font10">vectored </span>
   <span class="font10">year </span>
   <span class="font10">α(, </span>
  </p>
 </body>
</html>
